Johnson & Johnson Sees $1M in Unusual Options Activity as Stock Climbs 2.7% Toward 52-Week High

By TrendSpider Editor

A dominant put contract at the $240 strike accounted for $901,937.50 of the $1,021,012.50 in total unusual options premium flagged in Johnson & Johnson on Wednesday, drawing attention as JNJ shares rallied 2.70% to $230.45. The put activity carries a notably bearish tilt, with the largest contract s

Johnson & Johnson Sees $1M in Unusual Options Activity as Stock Climbs 2.7% Toward 52-Week High

A dominant put contract at the $240 strike accounted for $901,937.50 of the $1,021,012.50 in total unusual options premium flagged in Johnson & Johnson on Wednesday, drawing attention as JNJ shares rallied 2.70% to $230.45. The put activity carries a notably bearish tilt, with the largest contract sitting in-the-money and expiring in July, suggesting at least some institutional players are hedging or positioning for a pullback even as the stock pushes higher. With JNJ trading near the upper end of its 52-week range of $146.115 to $251.705, the proximity to that high adds context to why options traders may be reaching for downside protection at elevated levels.

Key Drivers of the JNJ Stock Move

The split between a near-term bullish call and a longer-dated bearish put paints a nuanced picture for JNJ heading into the back half of May. The $230 call expiring on May 15, 2026 suggests short-term traders are riding the current momentum, while the July $240 put with far greater premium commitment points to longer-horizon concern. JNJ has been navigating an active news cycle around litigation and its pharmaceutical pipeline, and any developments on those fronts before the July expiration could be the catalyst that determines which camp collects. Traders should monitor how the stock behaves around the $240 level, which now sits at the intersection of the put strike and meaningful resistance ahead of the 52-week high.

JNJ Unusual Options Activity

Total unusual contracts flagged: 2. Total combined premium: $1,021,012.50. Net flow direction leans bearish, with the put contract representing approximately 88% of total premium on the session.

JNJ Seasonality

Mid-May has historically been a transitional period for large-cap healthcare names like JNJ, as first-quarter earnings cycles wind down and attention shifts to pipeline updates and summer conference catalysts. The July 17, 2026 expiration on the dominant put contract aligns with the period just ahead of JNJ's typical second-quarter earnings window, which may be a key consideration behind the timing of that trade.

JNJ Relative Performance

JNJ's 2.70% gain on Wednesday is a notably strong single-session move for a mega-cap healthcare name with a market capitalization in the hundreds of billions. The stock at $230.45 sits well above its 52-week low of $146.115, representing a significant recovery off those lows, while still leaving approximately $21 of distance between the current price and the 52-week high of $251.705. Relative to the broader healthcare sector, a 2.70% daily move suggests JNJ outperformed most of its large-cap peers on the session.